In addition, some studies showed that ALDH1+CD44+ HNSCC cells expressed lower level of miR145 and thus inhibiting miR-145 has been adequate for driving the tumor-inducing characteristics in the ALDH1−CD44− HNSCC cells [167]. The gene discussed is CD44; the disease is neoplasm.